Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M79.6Revenue (TTM) $M114Net Margin (%)-66.5Altman Z-Score-3.3
Enterprise Value $M-93.5EPS (TTM) $-1.6Operating Margin %-66.0Piotroski F-Score2
P/E(ttm)--Beneish M-Score-4.2Pre-tax Margin (%)-66.2Higher ROA y-yY
Price/Book1.310-y EBITDA Growth Rate %--Quick Ratio3.1Cash flow > EarningsY
Price/Sales0.75-y EBITDA Growth Rate %-13.0Current Ratio3.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-27.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-76.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M49.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with INFI

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INFIGeorge Soros 2013-06-30 Sold Out -0.02%$16.192 - $50.09
($30.95)
$ 1.61-95%Sold Out0
INFIGeorge Soros 2013-03-31 Reduce-0.01%$32.93 - $49.37
($39.51)
$ 1.61-96%Reduce -46.67%40,000
INFIGeorge Soros 2012-12-31 Buy 0.03%$17.74 - $35.04
($25.26)
$ 1.61-94%New holding75,000
INFIFirst Eagle Investment 2012-06-30 Sold Out -0.0086%$11.84 - $13.88
($12.85)
$ 1.61-87%Sold Out0
INFIFirst Eagle Investment 2012-03-31 Reduce-0.01%$5.9781 - $12.16
($7.96)
$ 1.61-80%Reduce -54.94%180,000
INFIFirst Eagle Investment 2011-09-30 Reduce-0.01%$6.17 - $10.36
($7.87)
$ 1.61-80%Reduce -25.85%464,241
INFIWilbur Ross 2011-06-30 Sold Out $5.61 - $8.19
($6.53)
$ 1.61-75%Sold Out0
INFIWilbur Ross 2010-12-31 Reduce-0.02%$5.12 - $6.86
($6.13)
$ 1.61-74%Reduce -63.91%7,415
INFIFirst Eagle Investment 2010-12-31 Add0.01%$5.12 - $6.86
($6.13)
$ 1.61-74%Add 60.34%585,437
INFIWilbur Ross 2010-09-30 Reduce-0.01%$4.62 - $6.3
($5.51)
$ 1.61-71%Reduce -25.39%20,545
INFIFirst Eagle Investment 2010-09-30 Add$4.62 - $6.3
($5.51)
$ 1.61-71%Add 29.72%365,123
INFIFirst Eagle Investment 2010-06-30 Add0.01%$5.88 - $7.94
($6.59)
$ 1.61-76%Add 566.95%281,460
INFIFirst Eagle Investment 2009-12-31 Add$5.5 - $6.57
($5.92)
$ 1.61-73%Add 451.43%42,201
INFIFirst Eagle Investment 2009-09-30 Buy $5.42 - $8.8
($6.97)
$ 1.61-77%New holding7,653
INFIWilbur Ross 2009-03-31 Buy 0.12%$7.1 - $8.28
($7.9)
$ 1.61-80%New holding28,437
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INFI is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


INFI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Perkins Adelene QPresident & CEO 2015-06-25Sell5,000$10.93-85.27view
Palombella Vito J.Chief Scientific Officer 2015-06-15Sell4,737$10.97-85.32view
Perkins Adelene QPresident & CEO 2015-05-27Sell10,000$12.81-87.43view
Perkins Adelene QPresident & CEO 2015-05-14Sell10,000$12.18-86.78view
Perkins Adelene QPresident & CEO 2015-03-16Sell20,000$16-89.94view
Perkins Adelene QPresident & CEO 2015-03-05Sell25,000$16.5-90.24view
Perkins Adelene QPresident & CEO 2015-01-29Sell20,000$14.83-89.14view
Perkins Adelene QPresident & CEO 2015-01-29Sell20,000$14.83-89.14view
Palombella Vito J.Chief Scientific Officer 2014-12-15Sell4,737$16.32-90.13view
Palombella Vito J.Chief Scientific Officer 2014-11-26Sell4,736$15-89.27view

Quarterly/Annual Reports about INFI:

News about INFI:

Articles On GuruFocus.com
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 04 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) May 06 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 06 2009 
Infinity Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2009 

More From Other Websites
INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jul 26 2016
ETF’s with exposure to Infinity Pharmaceuticals, Inc. : July 18, 2016 Jul 18 2016
Infinis plc £350m 7% Senior Notes due 2019 Announcement of annual results for the year ended 31... Jul 06 2016
Infinity Regains Duvelisib Rights, Announces Restructuring Jun 29 2016
Call announcement Infinis plc annual results for the year ending 31 March 2016 £350m 7% Senior... Jun 29 2016
INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement,... Jun 28 2016
Infinity Regains Worldwide Rights To Duvelisib Following Mutual Agreement With AbbVie To End... Jun 28 2016
Infinity Regains Worldwide Rights To Duvelisib Following Mutual Agreement With AbbVie To End... Jun 28 2016
7 Stocks Under $10 to Trade for Big Post-Brexit Gains Jun 26 2016
INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security... Jun 22 2016
ETF’s with exposure to Infinity Pharmaceuticals, Inc. : June 20, 2016 Jun 20 2016
6 Companies That Destroyed Shareholders Last Week Jun 19 2016
Lifshitz & Miller Law Firm Announces Investigation of CBL & Associates Properties, Inc., Eagle... Jun 17 2016
[$$] Infinity Pharmaceuticals' Disappointing Data Jun 16 2016
Infinity Pharmaceuticals Faces Downgrades as Drug Results Disappoint Jun 15 2016
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Infinity... Jun 15 2016
Infinity Pharmaceuticals Cannot Cure Downgrades After Drug Study Jun 15 2016
6 Biopharma Movers Making a Run on Wednesday Jun 15 2016
Infinity (INFI) at 52-Week Low on Disappointing Duvelisib Data Jun 15 2016
Infinity Pharmaceutical downgraded by RBC Capital Mkts, Jefferies, Morgan Stanley and Wells Fargo Jun 15 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)